Nanoplasmonic multiplex biosensing for COVID-19 vaccines
The ongoing emergence of severe acute respiratory syndrome caused by the new coronavirus (SARS-CoV-2) variants requires swift actions in identifying specific antigens and optimizing vaccine development to maximize the humoral response of the patient. Measuring the specificity and the amount of antib...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier Ltd
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |